The effects of nitric oxide on the immune system during Trypanosoma cruzi infection

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 236-245

  Gutierrez, Fredy R S ^a   Mineo, Tiago W P ^a   Pavanelli, Wander R ^a   Guedes, Paulo M M ^a   Silva, João S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Myocarditis; Nitric oxide; Regulatory T cells; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 68949219809     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900030     Document Type: Article

References (126)

1. Abrahamsohn IA, Coffman RL 1995. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 155: 3955-3963.
2. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from Larginine. J Immunol 144: 2725-2729.
3. Aliberti JC, Machado FS, Souto JT, Campanelli AP, Teixeira MM, Gazzinelli RT, Silva JS 1999. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 67: 4819-4826.
4. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, Farber J, Gazzinelli RT, Silva JS 2001. Modulation of chemokine production and inflammatory responses in interferon-gamma-and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
5. Altclas J, Sinagra A, Dictar M, Luna C, Veron MT, De Rissio AM, Garcia MM, Salgueira C, Riarte A 2005. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 36: 123-129.
6. Alvarez MN, Piacenza L, Irigoin F, Peluffo G, Radi R 2004. Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch Biochem Biophys 432: 222-232.
7. Angelo M, Hausladen A, Singel DJ, Stamler JS 2008. Interactions of NO with hemoglobin: from microbes to man. Methods Enzymol 436: 131-168.
8. Arantes RM, Marche HH, Bahia MT, Cunha FQ, Rossi MA, Silva JS 2004. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am J Pathol 164: 1361-1368.
9. Baez AL, Lo Presti MS, Rivarola HW, Pons P, Fretes R, Paglini-Oliva P 2008. Trypanosoma cruzi: cardiac mitochondrial alterations produced by different strains in the acute phase of the infection. Exp Parasitol 120: 397-402.
10. Banick PD, Chen Q, Xu YA, Thom SR 1997. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 172: 12-24.
11. Benevides L, Milanezi CM, Yamauchi LM, Benjamim CF, Silva JS, Silva NM 2008. CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. Am J Pathol 173: 741-751.
12. Biffl WL, Moore EE, Moore FA, Barnett C 1996. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res 63: 328-332.
13. Bogdan C 2001. Nitric oxide and the immune response. Nat Immunol 2: 907-916.
14. Brunet LR 2001. Nitric oxide in parasitic infections. Int Immunopharmacol 1: 1457-1467.
15. Buscaglia CA, Campo VA, Frasch AC, Di Noia JM 2006. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat Rev Microbiol 4: 229-236.
16. Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT 1997. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 158: 5890-5901.
17. Campos MA, Gazzinelli RT 2004. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors. Mediators Inflamm 13: 139-143.
18. Cançado JR 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop São Paulo 44: 29-37.
19. Cardoni RL, Rottenberg ME, Segura EL 1990. Increased production of reactive oxygen species by cells from mice acutely infected with Trypanosoma cruzi. Cell Immunol 128: 11-21.
20. Carneiro-Sampaio M, Coutinho A 2007. Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun 75: 1545-1555.
21. Cattell V, Jansen A 1995. Inducible nitric oxide synthase in inflammation. Histochem J 27: 777-784.
22. Chen B, Deen WM 2001. Analysis of the effects of cell spacing and liquid depth on nitric oxide and its oxidation products in cell cultures. Chem Res Toxicol 14: 135-147.
23. Chung HT, Choi BM, Kwon YG, Kim YM 2008. Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. Methods Enzymol 441: 329-338.
24. Ciccarelli A, Araujo L, Batlle A, Lombardo E 2007. Effect of haemin on growth, protein content and the antioxidant defence system in Trypanosoma cruzi. Parasitology 134: 959-965.
25. Colasanti M, Gradoni L, Mattu M, Persichini T, Salvati L, Venturini G, Ascenzi P 2002. Molecular bases for the anti-parasitic effect of NO (review). Int J Mol Med 9: 131-134.
26. Coura JR 2007. Chagas disease: what is known and what is needed: a background article. Mem Inst Oswaldo Cruz 102 (Suppl. I): 113-122.
27. Cuzzocrea S, Chatterjee PK, Mazzon E, McDonald MC, Dugo L, Di Paola R, Serraino I, Britti D, Caputi AP, Thiemermann C 2002. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Eur J Pharmacol 453: 119-129.
28. Dal Secco D, Moreira AP, Freitas A, Silva JS, Rossi MA, Ferreira SH, Cunha FQ 2006. Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: role of soluble guanylate cyclase. Nitric Oxide 15: 77-86.
29. De Gouw HW, Marshall-Partridge SJ, Van Der Veen H, Van Den Aardweg JG, Hiemstra PS, Sterk PJ 2001. Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects. J Appl Physiol 90: 586-592.
30. De Groote MA, Fang FC 1995. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 21 (Suppl. 2): S162-165.
31. Denkers EY, Butcher BA 2005. Sabotage and exploitation in macrophages parasitized by intracellular protozoans. Trends Parasitol 21: 35-41.
32. Docampo R 1990. Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem Biol Interact 73: 1-27.
33. Eckmann L, Laurent F, Langford TD, Hetsko ML, Smith JR, Kagnoff MF, Gillin FD 2000. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determi-nants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 164: 1478-1487.
34. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, Konig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9: 1399-1406.
35. Fang FC 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity: J Clin Invest 99: 2818-2825.
36. Filardi LS, Brener Z 1987: Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81: 755-759.
37. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, DosReis GA, Lopes MF 2000. Up-take of apoptotic cells drives the growth of a pathogenic trypano-some in macrophages. Nature 403: 199-203.
38. Fukada SY, Silva TA, Saconato IF, Garlet GP, Avila-Campos MJ, Silva JS, Cunha FQ 2008. iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res 87: 1155-1159.
39. Furchgott RF, Zawadzki JV 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
40. Galvao LM, Nunes RM, Cançado JR, Brener Z, Krettli AU 1993. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans R Soc Trop Med Hyg 87: 220-223.
41. Garg N 2005. Mitochondrial disorders in chagasic cardiomyopathy. Front Biosci 10: 1341-1354.
42. Ghafourifar P, Cadenas E 2005. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26: 190-195.
43. Gilroy DW 2005. New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epilipoxins. Mem Inst Oswaldo Cruz 100 (Suppl. I): 49-54.
44. Goldstein J, Paveto C, Lopez-Costa JJ, Pereira C, Alonso G, Torres HN, Flawia MM 2000. Immuno and cytochemical localization of Trypanosoma cruzi nitric oxide synthase. Biocell 24: 217-222.
45. Gow AJ, Stamler JS 1998. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391: 169-173.
46. Gregory DJ, Olivier M 2005. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 130 (Suppl.): S27-35.
47. Grisham MB, Granger DN, Lefer DJ 1998. Modulation of leukocyteendothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 25: 404-433.
48. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Lid-dington RC, Lipton SA 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-1190.
49. Guedes PMM, Fietto JLR, Lana M, Bahia MT 2006. Advances in Chagas disease chemotherapy. Anti-Infect Agents Med Chem 5: 11.
50. Gutierrez FR, Lalu MM, Mariano FS, Milanezi CM, Cena J, Gerlach RF, Santos JE, Torres-Duenas D, Cunha FQ, Schulz R, Silva JS 2008. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis 197: 1468-1476.
51. Hokari R, Miura S, Fujimori H, Tsuzuki Y, Shigematsu T, Higuchi H, Kimura H, Kurose I, Serizawa H, Suematsu M, Yagita H, Granger DN, Ishii H 1998. Nitric oxide modulates T-lymphocyte migration in Peyer's patches and villous submucosa of rat small intestine. Gastroenterology 115: 618-627.
52. Huerta S, Chilka S, Bonavida B 2008. Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33: 909-927.
53. James SL 1995. Role of nitric oxide in parasitic infections. Microbiol Rev 59: 533-547.
54. Jana M, Dasgupta S, Pal U, Pahan K 2009. IL-12 p40 homodimer, the so-called biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12Rbeta1. Glia, in press.
55. Johann AM, Barra V, Kuhn AM, Weigert A, von Knethen A, Brune B 2007. Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production. Faseb J 21: 2704-2712.
56. Kanneganti TD, Lamkanfi M, Nunez G 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559.
57. Klotz FW, Scheller LF, Seguin MC, Kumar N, Marletta MA, Green SJ, Azad AF 1995. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol 154: 3391-3395.
58. Larrainzar E, Urarte E, Auzmendi I, Ariz I, Arrese-Igor C, Gonzalez EM, Moran JF 2008. Use of recombinant iron-superoxide dismutase as a marker of nitrative stress. Methods Enzymol 437: 605-618.
59. Leiriao P, Rodrigues CD, Albuquerque SS, Mota MM 2004. Survival of protozoan intracellular parasites in host cells. EMBO Rep 5: 1142-1147.
60. Livonesi MC, Rossi MA, de Souto JT, Campanelli AP, de Sousa RL, Maffei CM, Ferreira BR, Martinez R, da Silva JS 2009. Inducible nitric oxide synthase-deficient mice show exacerbated inflammatory process and high production of both Th1 and Th2 cytokines during paracoccidioidomycosis. Microbes Infect 11: 123-132.
61. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S 1996. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314: 877-880.
62. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD 1999. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104: 1041-1050.
63. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS 2000. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102: 3003-3008.
64. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, Aliberti J, Silva JS 2008. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10: 1558-1566.
65. MacMicking J, Xie QW, Nathan C 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
66. Malvezi AD, Cecchini R, de Souza F, Tadokoro CE, Rizzo LV, Pinge-Filho P 2004. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. FEMS Immunol Med Microbiol 41: 69-77.
67. +T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 10: 825-833.
68. Marnett LJ, Riggins JN, West JD 2003. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 111: 583-593.
69. Martins GA, Cardoso MA, Aliberti JC, Silva JS 1998. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett 63: 113-120.
70. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A 1997. S-nitrosylation regulates apoptosis. Nature 388: 432-433.
71. Michailowsky V, Murta SM, Carvalho-Oliveira L, Pereira ME, Fer-reira LR, Brener Z, Romanha AJ, Gazzinelli RT 1998. Interleu-kin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrob Agents Chemother 42: 2549-2556.
72. Molina J, Martins-Filho O, Brener Z, Romanha AJ, Loebenberg D, Urbina JA 2000. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother 44: 150-155.
73. Monteiro AC, Schmitz V, Morrot A, de Arruda LB, Nagajyothi F, Granato A, Pesquero JB, Muller-Esterl W, Tanowitz HB, Scharf-stein J 2007. Bradykinin B2 receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog 3: e185.
74. Murad F 1986. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78: 1-5.
75. Murray HW, Nathan CF 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189: 741-746.
76. Nathan C, Shiloh MU 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97: 8841-8848.
77. Niedbala W, Wei XQ, Piedrafita D, Xu D, Liew FY 1999. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 29: 2498-2505.
78. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO 2003. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896-899.
79. Okuda Y, Sakoda S, Shimaoka M, Yanagihara T 1996. Nitric oxide induces apoptosis in mouse splenic T lymphocytes. Immunol Lett 52: 135-138.
80. Packard KA, Khan MM 2003. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 3: 909-920.
81. Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM 2001. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J Biol Chem 276: 7899-7905.
82. Paveto C, Pereira C, Espinosa J, Montagna AE, Farber M, Esteva M, Flawia MM, Torres HN 1995. The nitric oxide transduction pathway in Trypanosoma cruzi. J Biol Chem 270: 16576-16579.
83. Pereira CA, Alonso GD, Paveto MC, Flawia MM, Torres HN 1999. L-arginine uptake and L-phosphoarginine synthesis in Trypanosoma cruzi. J Eukaryot Microbiol 46: 566-570.
84. Pfeilschifter J, Eberhardt W, Beck KF 2001. Regulation of gene expression by nitric oxide. Pflugers Arch 442: 479-486.
85. Piacenza L, Peluffo G, Radi R 2001. L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Proc Natl Acad Sci USA 98: 7301-7306.
86. Poderoso JJ 2009. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys 484: 214-220.
87. Poulos TL 2006. Soluble guanylate cyclase. Curr Opin Struct Biol 16: 736-743.
88. Rassi A, Amato Neto V, de Siqueira AF, Ferriolli Filho F, Amato VS, Rassi Junior A 1999. Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases. Rev Soc Bras Med Trop 32: 475-482.
89. Ribeiro JM, Hazzard JM, Nussenzveig RH, Champagne DE, Walker FA 1993. Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect. Science 260: 539-541.
90. Richardson DR, Lok HC 2008. The nitric oxide-iron interplay in mammalian cells: transport and storage of dinitrosyl iron complexes. Biochim Biophys Acta 1780: 638-651.
91. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA 2007. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci USA 104: 16898-16903.
92. Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, Ochoa JB, Ochoa AC 2003. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 171: 1232-1239.
93. Russo M, Starobinas N, Ribeiro-Dos-Santos R, Minoprio P, Eisen H, Hontebeyrie-Joskowicz M 1989. Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi. Parasite Immunol 11: 385-395.
94. Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A 1998. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59: 487-491.
95. Sakaguchi S 2004. Naturally arising CD4+regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
96. Salvucci O, Kolb JP, Dugas B, Dugas N, Chouaib S 1998. The induction of nitric oxide by interleukin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activity. Blood 92: 2093-2102.
97. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA 2000. Reactive nitrogen and oxygen species attenuate interleukin- 8-in-duced neutrophil chemotactic activity in vitro. J Biol Chem 275: 10826-10830.
98. Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, Aoki M del P, Bottasso O, Guinazu N, Silva-Barbosa SD, Gea S 2007. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev 18: 107-124.
99. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R 2001. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950.
100. Schwarcz de Tarlovsky MN, Rilo MC, Hernandez SM, Bedoya AM, Lammel EM, Isola EL 1995. Spermine action on mitochondrial H(+)-ATPase activity and proliferation rate of Trypanosoma cruzi. Cell Mol Biol 41: 861-866.
101. Shi CS, Shi GY, Hsiao SM, Kao YC, Kuo KL, Ma CY, Kuo CH, Chang BI, Chang CF, Lin CH, Wong CH, Wu HL 2008. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 112: 3661-3670.
102. Shibata T, Nagata K, Kobayashi Y 2007. Cutting edge: a critical role of nitrogen oxide in preventing inflammation upon apoptotic cell clearance. J Immunol 179: 3407-3411.
103. Silva JJ, Osakabe AL, Pavanelli WR, Silva JS, Franco DW 2007. In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors. Br J Pharmacol 152: 112-121.
104. Silva JS, Aliberti JC, Martins GA, Souza MA, Souto JT, Padua MA 1998. The role of IL-12 in experimental Trypanosoma cruzi infection. Braz J Med Biol Res 31: 111-115.
105. Silva JS, Machado FS, Martins GA 2003. The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci 8: S314-325.
106. Singh VK, Mehrotra S, Narayan P, Pandey CM, Agarwal SS 2000. Modulation of autoimmune diseases by nitric oxide. Immunol Res 22: 1-19.
107. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yam-potis C 1998. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 59: 526-529.
108. Staykova MA, Berven LA, Cowden WB, Willenborg DO, Crouch MF 2003. Nitric oxide induces polarization of actin in encepha-litogenic T cells and inhibits their in vitro trans-endothelial migration in a p70S6 kinase-independent manner. Faseb J 17: 1337-1339.
109. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
110. Tarleton RL 2007. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 19: 430-434.
111. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Gar-side P, Padron J, Phillips RS 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 980-984.
112. Teixeira MM, Gazzinelli RT, Silva JS 2002. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18: 262-265.
113. Trujillo M, Ferrer-Sueta G, Radi R 2008. Peroxynitrite detoxification and its biologic implications. Antioxid Redox Signal 10: 1607-1620.
114. Underhill DM 2007. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev 219: 75-87.
115. Urbina JA 1999. Parasitological cure of Chagas disease: is it possible? Is it relevant? Mem Inst Oswaldo Cruz 94 (Suppl. I): 349-355.
116. Uyemura SA, Albuquerque S, Curti C 1995. Energetics of heart mitochondria during acute phase of Trypanosoma cruzi infection in rats. Int J Biochem Cell Biol 27: 1183-1189.
117. van der Veen RC 2001. Nitric oxide and T helper cell immunity. Int Immunopharmacol 1: 1491-1500.
118. van Wely CA, Blanchard AD, Britten CJ 1998. Differential expression of alpha3 fucosyltransferases in Th1 and Th2 cells correlates with their ability to bind P-selectin. Biochem Biophys Res Commun 247: 307-311.
119. Venturini G, Salvati L, Muolo M, Colasanti M, Gradoni L, Ascenzi P 2000. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi. Biochem Biophys Res Commun 270: 437-441.
120. Vespa GN, Cunha FQ, Silva JS 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 62: 5177-5182.
121. Vyatkina G, Bhatia V, Gerstner A, Papaconstantinou J, Garg N 2004. Impaired mitochondrial respiratory chain and bioenergetics dur-ing chagasic cardiomyopathy development. Biochim Biophys Acta 1689: 162-173.
122. Wen JJ, Yachelini PC, Sembaj A, Manzur RE, Garg NJ 2006. Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic Biol Med 41: 270-276.
123. Wynn TA, Oswald IP, Eltoum IA, Caspar P, Lowenstein CJ, Lewis FA, James SL, Sher A 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 153: 5200-5209.
124. Xiao BG, Ma CG, Xu LY, Link H, Lu CZ 2008. IL-12/IFN-gamma/ NO axis plays critical role in development of Th1-mediated ex-perimental autoimmune encephalomyelitis. Mol Immunol 45: 1191-1196.
125. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
126. Yeh CL, Hsu CS, Chen SC, Hou YC, Chiu WC, Yeh SL 2007. Effect of arginine on cellular adhesion molecule expression and leukocyte transmigration in endothelial cells stimulated by biological fluid from surgical patients. Shock 28: 39-44.